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Objective: The timing and urgency of salvage attempts for acutely thrombosed hemodialysis vascular accesses remain
poorly deﬁned. We examined the outcome of early surgical thrombectomy after acute access thrombosis to assess the
inﬂuence of expedited timing on access salvage.
Methods: Between January 2007 and October 2012, 114 surgical thrombectomy attempts were performed on 82 patients
to salvage 89 accesses. The time between the diagnosis of thrombosis and admission to the operative suite (T1), the time
between diagnosis and the following dialysis session (T2), and clinical and biologic parameters were collected prospec-
tively. Data were retrospectively compared between the early (T1 <6 hours) and later (T1 >6 hours) treatment groups.
The main outcome measure was technical success. Kaplan-Meier survival analysis was used to estimate functional patency
rates.
Results: Mean patient follow-up was 22 6 18 months. The mean time from referral to procedure (T1) was 5.7 6
4.5 hours. The mean time T1 was 3.6 6 1.2 hours in the early group and 10.3 6 5.4 hours in the later group. The mean
time to dialysis (T2) was 14.3 6 6.5 hours in the early group and 23.9 6 9.4 hours in the later group. Thrombectomy
performed #6 hours after diagnosis (T1 <6 hours) had signiﬁcantly higher technical success of 86% compared with 69%
for thrombectomy performed later (T1 >6 hours; P [ .04). The two groups did not differ signiﬁcantly in patient
comorbidities, type of access, or adjunctive procedures performed (P$ .1). At 12 months, the primary patency rate for all
index cases, including technical failures, was 55% 6 7.1% in the early group and 33% 6 9.7% in the later group (P[ .13).
The secondary patency rate was 67% 6 6.8% in the early group and 50% 6 9.9% in the later group (P [ .05).
Conclusions: After acute access thrombosis, early surgical thrombectomy was associated with higher technical success and
potentially improved midterm patency. (J Vasc Surg 2014;59:1377-84.)Acute thrombosis is a signiﬁcant complication of he-
modialysis vascular access that leads to morbidity, hos-
pitalization, salvage procedures, potentially new access
placement, and associated costs.1,2 The National Kidney
Foundation-Kidney Disease Outcomes Quality Initiative
(NKF-KDOQI) guidelines recommend attempting access
salvage as early as possible after thrombosis and also state
that thrombectomy can be effective after several days.3
Owing to the lack of published evidence, this practical
recommendation remains misunderstood by many. The ur-
gency of treatment of acute access thrombosis is often
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://dx.doi.org/10.1016/j.jvs.2013.11.092treatment can be associated with an increased need for
placement of short-term dialysis catheters, with their latent
short-term and long-term complications.4 Therefore, we
examined the outcome of early surgical thrombectomy af-
ter acute access thrombosis to assess the inﬂuence of expe-
dited timing on access salvage.
METHODS
The clinical data of patients who underwent surgical
thrombectomy of their hemodialysis vascular access in the
Department of Vascular Surgery at the University of Nice
between January 2007 and October 2012 were prospec-
tively collected in a secured computerized database and
retrospectively analyzed. The study was conducted accord-
ing to the Declaration of Helsinki, and our institutional
Ethics Committee approved the protocol.
Patients were immediately referred to a vascular sur-
geon by the treating nephrologist after the diagnosis of
thrombosis. Early-access thrombosis (eg, <30 days after
the original access creation) was not included in this study
because emergent access salvage was attempted for all
autologous and prosthetic functional vascular accesses
with acute thrombosis. Preinterventional urgent hemodial-
ysis was undertaken using a short-term jugular or femoral
catheter only in cases of life-threatening clinical deteriora-
tion such as serum potassium >6.5 mmol/L or acute pul-
monary edema. Patients with acute access thrombosis
>30 days after the original procedure were taken to the1377
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study.
The surgical thrombectomy was performed in the
operative suite by an experienced vascular surgeon with
the patient under local anesthesia and intravenous sedation.
Patients were brought to the operating room as early as
possible; our service has two rooms for elective cases and
one for emergent cases.
The surgical technique consisted of milking the
thrombus from the thrombosed access (manual clot re-
moval) as described by Cull et al,5 adapted for prosthetic
grafts, as well as ﬁstulas, as originally described. A ﬁstulo-
gram was performed when technically feasible to conﬁrm
the completion of thrombectomy and to ﬁnd a cause of ac-
cess failure. Stenoses were treated in the same procedure
with balloon angioplasty and stent placement or surgical
revision, including total or partial conduit replacement
and venous or prosthetic patch placement. Failed throm-
bectomies led to access abandonment and placement of a
short-term catheter for the following dialysis, with a new
vascular access created during the same procedure or
planned within a short time. Procedures were performed
as outpatient treatments if possible, unless timing of hemo-
dialysis was facilitated by an overnight admission.
The treating nephrologist and the vascular surgeon
both monitored the access during follow-up. In our prac-
tice, nephrologists carefully follow-up the patients with
clinical examination as well as ﬂow measurement during
the dialysis session. Doppler ultrasound imaging is per-
formed if stenosis or thrombosis is suspected.
Demographic data and cardiovascular risk factors were
recorded for each patient, as were the number, location,
and type of any current or previous access. The time be-
tween the diagnosis of vascular access thrombosis and the
admission to the operative suite was recorded as T1, and
the time between the diagnosis and the following dialysis
session was recorded as T2. Information regarding surgical
intervention and access outcome, such as complications
and functional patency, were also recorded. Data were
retrospectively analyzed with comparison between the early
(T1 <6 hours) and later (T1 >6 hours) treatment groups.
The main outcome measure was technical success,
deﬁned as the re-establishment of a functional access
that was used for the following dialysis session. Any surgi-
cal replacement of the access puncture zone was recorded
as a technical failure. The secondary outcome was func-
tional patency rate. An access was deﬁned as functional
when able to deliver a ﬂow rate of 350 to 400 mL/min
without access recirculation to maintain a treatment time
of <4 hours.6
Primary patency was deﬁned as the interval from the
time of the initial thrombectomy procedure (index proce-
dure) until any intervention designed to maintain or re-
establish patency, or until access rethrombosis. Secondary
patency was deﬁned as the interval from the time of the in-
dex procedure until access abandonment, rethrombosis, or
performance of interventions designed to maintain or re-
establish functionality in a thrombosed access.Statistical analysis was performed with StatView 5.0
software (SAS Institute Inc, Cary, NC). All results were
calculated on an intention-to-treat-basis. Nominal variables
are expressed as a number and a percentage of patients or
access. Differences of categoric variables were assessed by
the two-tailed Fisher exact test. Continuous variables are
expressed as the mean 6 standard deviation. Differences
between continuous variables were assessed by a two-
tailed unpaired t-test or by nonparametric tests for non-
Gaussian variables. Variables analyzed with univariable tests
with a value of P < .10 were analyzed using logistic regres-
sion analysis and reported as odds ratios (ORs) with 95%
conﬁdence intervals (CIs). Kaplan-Meier analysis was
used to calculate patency curves and survival after index
procedures, with curves compared using log-rank and
Breslow-Gehan-Wilcoxon analyses. The Cox proportional
hazards regression model was used to control potentially
confounding factors for censored variables. Differences
were expressed as hazard ratios with 95% CIs. A value of
P < .05 was considered signiﬁcant.
RESULTS
During the study period, 82 patients underwent 114
surgical thrombectomy procedures to salvage a throm-
bosed vascular access. Seven patients had two or more
vascular access sites, leading to 89 index procedures on
89 accesses. Patient demographics and access characteris-
tics are summarized in Table I. Mean patient follow-up
was 22 6 18 months. Two patients were lost to follow-
up at 1 month.
The mean time between the diagnosis of vascular ac-
cess thrombosis and the admission to the operative suite
(T1) was 5.7 6 4.5 hours. The mean time T1 was 3.6 6
1.2 hours in the early group and 10.3 6 5.4 hours in the
later treatment group. Fig 1 shows the distribution of
time to procedure (T1) in the cohort and shows an early
group with a normal distribution and a later group with
even distribution. Only 20 to 30 minutes were required
for transport of most patients from their place of referral
to our center. Four patients required emergent hemodialy-
sis with a short-term catheter before the surgical procedure
for life-threatening elevations in serum potassium (n ¼ 3)
or acute pulmonary edema (n ¼ 1).
Stenosis was identiﬁed as the etiology for vascular
access thrombosis in all but one procedure; stenoses were
typically in the venous outﬂow, although they occurred
at all sites. The remaining access was thought to be throm-
bosed due to severe cardiac dysfunction with a concomi-
tant low-ﬂow state. Table II lists the adjunctive
procedures performed after the thrombectomy and the
mean procedure times. More surgical revisions were per-
formed in the later group, although the difference was
not statistically signiﬁcant (P ¼ .09).
The overall technical success rate was 81% (92 of 114;
Table III). A short-term catheter was necessary after 20
technical failures (18%). Catheter placement was avoided
in the two remaining failed procedures: another func-
tional vascular access was created in one patient in
Table I. Patient demographics and risk factors
Variablesa Total (N ¼ 82) T1 <6 hours (n ¼ 54) T1 >6 hours (n ¼ 28) P
Age, years 66 6 16 66 6 17 68 6 15 .63
Gender .35
Male 43 (52) 30 (56) 12 (43)
Female 39 (48) 24 (44) 16 (57)
Diabetes 27 (33) 16 (30) 11 (39) .45
Hypertension 38 (46) 26 (48) 12 (43) .81
Ischemic cardiac disease 28 (34) 21 (39) 7 (25) .23
Cardiac arrhythmias 12 (15) 8 (15) 4 (14) >.99
Pulmonary disease 15 (18) 9 (17) 5 (18) >.99
Ongoing treatments
Statin 35 (43) 27 (50) 8 (29) .10
Anticoagulant 17 (21) 13 (24) 4 (14) .39
Antiplatelet 28 (34) 19 (35) 9 (32) .81
Erythropoietin (intravenous, during dialysis) 74 (90) 48 (89) 26 (93) .71
Access (N ¼ 89) (n ¼ 59) (n ¼ 30)
Type >.99
Autologous ﬁstulas and grafts 59 (66) 39 (66) 20 (67)
Prosthetic grafts 30 (34) 20 (34) 10 (33)
Time to thrombosis from creation to index
procedure, months
27 6 35 30 6 28 21 6 18 .10
History of previous thrombosis on the same access 24 (27) 16 (27) 8 (27) >.99
T1, Mean time from referral to procedure.
aContinuous data are shown as mean 6 standard deviation and categoric data as number (%).
Fig 1. Distribution of time to procedure (duration T1, time between the diagnosis and the thrombectomy attempt).
Total of 114 procedures.
Table II. Adjunctive procedures
Proceduresa
Total
(N ¼ 114)
T1 <6 hours
(n ¼ 78)
T1 >6 hours
(n ¼ 36) P
Fistulogram 90 (79) 62 (79) 28 (78) .81
Angioplasty 74 (65) 52 (67) 22 (61) .67
Stent 18 (16) 10 (13) 8 (22) .27
Surgical revision 26 (23) 14 (18) 12 (33) .09
Duration, min 90 6 30 90 6 33 91 6 28 .90
T1, Mean time from referral to procedure.
aContinuous data are shown as mean 6 standard deviation and categoric
data as number (%).
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tion, and in the other patient, puncture of a newly created
brachiocephalic ﬁstula was permitted because of a maturevenous line (above a radiocephalic ﬁstula). Three failures
occurred #12 hours after a successful thrombectomy
from unknown etiology. The technical success rate was
87% in accesses without a history of previous throm-
bosis compared with 70% in accesses with a history of
previous thrombosis. Thrombectomy attempts per-
formed #6 hours (T1 <6 hours) after diagnosis had
signiﬁcantly higher technical success of 86% compared
with 69% for procedures performed later (T1
$6 hours; Table III). These variables were both signif-
icant when analyzed with multivariable analysis (OR,
3.11; 95% CI, 1.16-8.34; P ¼ .02; and OR, 2.96;
95% CI, 1.10-7.98; P ¼ .03, respectively). Table III
compares technical success rates between the early and
later treatment group within different subgroups of
the cohort.
Table III. Technical success rates, with subgroup analysis based on T1 by Fisher exact test
Variablesa
Technical success rates
All procedures T1 <6 hours T1 >6 hours P
92/114 (81) 67/78 (86) 25/36 (69) .04
Age, years 69 6 16 70 6 15 66 6 17 .29
Gender
Male 48/58 (83) 37/43 (86) 11/15 (73) .27
Female 44/56 (79) 30/35 (86) 14/21 (67) .11
Diabetes 29/34 (67) 18/20 (90) 11/14 (79) .63
Hypertension 43/53 (81) 33/38 (87) 10/15 (67) .12
Ischemic cardiac disease 36/41 (88) 29/32 (91) 7/9 (78) .30
Cardiac arrhythmias 13/16 (81) 10/11 (91) 3/5 (60) .21
Pulmonary disease 18/20 (90) 13/15 (87) 5/5 (100) >.99
Statin 45/56 (80) 36/44 (82) 9/12 (75) .69
Anticoagulant 15/20 (75) 11/14 (79) 4/6 (67) .61
Antiplatelet 34/42 (81) 25/30 (83) 9/12 (75) .67
Erythropoietin 86/105 (82) 61/71 (86) 25/34 (74) .79
Type of access
Autologous 60/74 (81) 43/51 (84) 17/23 (74) .34
Prosthetic 32/40 (80) 24/27 (89) 8/13 (62) .09
History of previous thrombosis 31/44 (70) 24/31 (77) 7/13 (54) .16
T1, Mean time from referral to procedure.
aContinuous data are shown as mean 6 standard deviation and categoric data as number (%).
Fig 2. Kaplan-Meier analysis shows cumulative patency after thrombectomy attempts for all index cases. SE, Standard error.
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of thrombosed access and the following dialysis session
(T2) was 17.3 6 8.8 hours. The mean time T2 was
14.3 6 6.5 hours in the early and 23.9 6 9.4 hours in
the later treatment groups. Delayed dialysis was not identi-
ﬁed as a cause of complication after any of the 114
procedures.The overall survival rate was 82% 6 5% at 12 months.
Two patients with severe comorbidities died of multisystem
organ failure (2%) within the postoperative period (#30
days). Primary patency was 47% at 1 year and 35% at 2 years
after all index procedures, whereas secondary patency was
61% at 1 year and 46% at 2 years (Fig 2). After successful
thrombectomy, primary patency was 56% at 1 year and
Fig 3. Cumulative (A) primary patency and (B) secondary patency by Kaplan-Meier analysis, with comparison of
curves with Breslow-Gehan-Wilcoxon analysis, is shown after thrombectomy attempts for all index cases. Subgroup
analysis depended on time to procedure T1 (<6 hours or >6 hours). SE, Standard error.
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and 56% at 2 years (data not shown). At 1 year, the primary
patency rate for all index procedures was 55% in the early
group and 33% in the later group (log-rank, P ¼ .26;
Breslow-Gehan-Wilcoxon, P ¼ .13; Fig 3, A). The second-
ary patency rate was 67% in the early group and 50% in the
later group (Fig 3, B); the comparison of the two curves
with the Breslow-Gehan-Wilcoxon test shows improved sec-
ondary patency (P ¼ .05; log-rank, P ¼ .16).To determine the effect of access type on outcome,
outcome after thrombectomy of autologous accesses was
compared with prosthetic accesses. Technical success rates
were similar between autologous and prosthetic accesses
(81% vs 80%, respectively; P > .99). For prosthetic ac-
cesses, there was a trend toward higher technical success
rate in the early treatment group (P ¼ .09; Table III).
Fig 4 shows the patency curves of autologous (A) and
prosthetic grafts (B), including all index cases. Among
Fig 4. Kaplan-Meier analysis shows cumulative patency after thrombectomy attempts and subgroup analysis of (A)
autologous ﬁstulas vs (B) prosthetic access grafts for index cases. C, Secondary patency is shown for autologous vs
prosthetic accesses, with exclusion of technical failures. SE, Standard error.
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ary patency was 77% at 1 year after successful thrombec-
tomy compared with 55% and 67% among prosthetic
accesses, respectively. Although autologous accesses were
associated with a trend toward higher primary patency
(P ¼ .09, data not shown), they had higher secondary
patency rates compared with prosthetic accesses (log-
rank, P ¼ .01; Fig 4, C). Similarly, multivariable Cox
analysis showed that autologous access was signiﬁcantly
associated with increased patency (hazard ratio, 0.51;
95% CI, 0.27-0.96; P ¼ .01). The duration T1 was not
associated with patency in the subgroup analysis between
autologous and prosthetic access (P > .2; Supplementary
Fig, online only).
DISCUSSION
In a practice where early thrombectomy is the rule,
thrombectomy performed #6 hours after diagnosis had
signiﬁcantly better outcome than thrombectomy per-
formed >6 hours (Table III). We believe that this is the
ﬁrst report demonstrating that time to performance of
the procedure can improve access salvage. These results
conﬁrm the NKF-DOQI paradigm, suggesting that
vascular access thrombosis is an emergency for the access.3
Our overall technical success rate was 81%, which is in
the range of previously published data for open thrombec-
tomies for autologous and prosthetic accesses.5,7-12 One
could have expected higher success rates; however, 39%
of our thrombectomy cohort presented with a history of
previous thrombosis. Our results with this high-risk group
conﬁrmed that reintervention after a previous thrombosis
was less likely to be successful, as previously suggested.13
In addition, as a tertiary center that manages complicated
access cases, our high proportion of complex cases, such
as reoperations and unusual access sites, makes compari-
son with published data on homogeneous cohorts more
difﬁcult.
Lack of power in the subgroup analysis of our cohort did
not allow us to prove that time to thrombectomy attempt in-
ﬂuences long-term patency. However, studies on lower limb
veins have shown that prolonged thrombosis is responsible
for venous wall inﬂammation, characterized by cell and ma-
trix proliferation as well as by endothelial dysfunction. Thick-
ening, ﬁbrosis, and loss of venous wall compliance may favor
rethrombosis.14,15 In thrombosed autologous ﬁstulas, this
inﬂammatory process appears early after thrombosis and
may explain low patency after thrombectomy.16 In arterio-
venous prosthetic grafts, >90% of failures were attributed
to intimal hyperplasia of the venous anastomosis.13,17,18
Furthermore, the prosthetic graft develops neointimal hy-
perplasia after implantation and is no longer an inert mate-
rial.19 However, our data do not clarify how much time
passes between the onset of thrombosis and subsequent
venous wall injury. We only found that autologous accesses
had higher post-thrombectomy patency rates than pros-
thetic grafts, conﬁrming previously published data.13,20,21
Short-term catheter placement and use are by no means
trivial. Consequences for the patient range from discomfortand pain to infection, central vein thrombosis, and eventu-
ally, death.22,23 Although it was impossible to predict how
many unnecessary short-term catheters (and their latent
complications) would have been avoided with early throm-
bectomy, we believe that our usage of 18% is a very low
number. Rates of catheter placement after access thrombosis
are rarely published, but a recent meta-analysis reported an
average of 26% based on three prospective studies.9
We acknowledge some limitations to our study. This
was a single-center, nonrandomized, noncontrolled study.
Our cohort was heterogeneous in access type, making
comparison with previous success and patency data difﬁ-
cult. This study was not designed to prove the efﬁciency
of our surgical thrombectomy technique but rather the in-
ﬂuence of its prompt implementation on access salvage.
Indisputable evidence in favor of any thrombectomy tech-
nique is still lacking.7,13 Our early thrombectomy policy
was also limited by objective data regarding the exact onset
of access thrombosis, as limited by detection of the refer-
ring physician.
Finally, larger studies will be needed to tell whether
autologous and prosthetic access should be treated the
same or differently regarding time to thrombectomy
attempt. The small number of patients in this study in-
creases the likelihood of a type II error and increases the
portion of the survival curves with a standard error of>10%.
CONCLUSIONS
Our study tends to conﬁrm that early surgical throm-
bectomy, attempted as soon as possible after referral for ac-
cess thrombosis, is associated with higher technical success
and potentially better midterm patency. Improved salvage
may allow reduced numbers of access catheters to be
placed, thus reducing patient morbidity and concomitant
costs of care.
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Supplementary Fig (online only). Kaplan-Meier and Breslow-Gehan-Wilcoxon analysis show cumulative patency
after thrombectomy attempts and subgroup analysis of autologous vs prosthetic accesses depending on time to pro-
cedure T1 (<6 hours or >6 hours) for all index cases. A, Primary and (B) secondary patency are shown for autologous
ﬁstulas. SE, Standard error.
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Supplementary Fig (online only). Continued. C, Primary and (D) secondary patency are shown for prosthetic grafts.
SE, Standard error.
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